Pencil Beam Scanning in Patients With Renal Tumors

Description

This is a pilot study to assess acute toxicity in patients receiving flank irradiation using proton therapy for renal tumors.

Conditions

Renal Tumor, Wilms Tumor

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a pilot study to assess acute toxicity in patients receiving flank irradiation using proton therapy for renal tumors.

Pilot Study of Pencil Beam Scanning Proton Beam Radiation Therapy in Patients With Renal Tumors

Pencil Beam Scanning in Patients With Renal Tumors

Condition
Renal Tumor
Intervention / Treatment

-

Contacts and Locations

Philadelphia

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States, 19104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Less than 30 years of age
  • * Diagnosis
  • 1. Any patient with favorable histology (FH), stage III disease
  • 2. Any patient with focal or diffuse anaplasia
  • 3. Any patient with CCSK
  • * The patient is a candidate for external beam radiotherapy based on standard of care for treatment of Wilms tumor or CCSK
  • * Prior radiotherapy to the region of the study cancer
  • * Chemotherapy administered for diagnosis of Wilms tumor or CCSK
  • * Pregnant or breastfeeding

Ages Eligible for Study

0 Years to 30 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Children's Hospital of Philadelphia,

Christine Hill-Kayser, MD, PRINCIPAL_INVESTIGATOR, Children's Hospital of Philadelphia

Study Record Dates

2025-09-30